Feb 8, 2024
Jawdrop Summit Welcomes MediSieve's CEO as Panelist on Ageing and Health
Dr George Frodsham, CEO of MediSieve, was invited as a panelist at the Jawdrop Life Sciences Summit to discuss ageing, pandemics, and antimicrobial resistance alongside other distinguished experts.
LONDON, February 10, 2024 – MediSieve, a pioneering London-based BioTech startup, proudly participated in the recent Jawdrop Life Sciences Summit organised by Upstream. The 2024 Summit focused on critical topics such as Ageing, Pandemics, and Antimicrobial Resistance (AMR), featuring a lineup of esteemed panelists and thought-provoking discussions.
Dr George Frodsham, CEO of MediSieve, shared his expertise on the Ageing panel, engaging in a vital conversation alongside notable experts including Professor Payam Barnaghi of Imperial College London and the UK Dementia Research Institute, Dhivya Venkat, CEO of Esya Labs, Nicola Lang, Director of Public Health at the Hammersmith & Fulham Council, Inga Deakin from Molten Ventures, and Chris Ward from UKRI's Healthy Ageing Challenge.
The panel discussed innovative approaches and ongoing challenges in tackling ageing-related health issues. Dr Frodsham’s insights highlighted the potential of Magnetic Blood Filtration technology in addressing complex diseases associated with ageing.
"We are immensely grateful to the Upstream team for the opportunity to share our vision and discuss future healthcare solutions with such a distinguished group of professionals," said Dr Frodsham. "Participating in these conversations not only enhances our understanding but also aligns with our goals of advancing healthcare technology and improving patient outcomes."
The Jawdrop Summit serves as a crucial platform for collaboration and discourse among the brightest minds in the life sciences sector, driving forward the conversation on how to tackle some of the most pressing health challenges of our time.
About MediSieve
MediSieve is an innovative BioTech company based in the White City Innovation District of West London. A spin-off from University College London, MediSieve is dedicated to developing its Magnetic Blood Filtration technology, a transformative approach to physically removing or isolating substances from the bloodstream. The company continues to seek investment and partnerships to advance its technology for broader applications in healthcare.
MEDIA CONTACT:
Alina Kagermazova
Email: alina@medisieve.co.uk
INVESTOR AND PARTNERSHIP CONTACT:
George Frodsham
Email: george@medisieve.co.uk
